2m 2m 2m 2m 2m 2m 2m
Champns Onclgy (CSBR)
NASDAQ
$5.61-$0.08 (-1.41%)
Price as of Jun 03, 2026 4:10 PM EDT- $81.0MMarket Cap
- -10.82%1-Year Change
- BiotechnologyIndustry
Champns Onclgy (CSBR)
$5.61-$0.08 (-1.41%)
Annual
Quarterly
04/30/2025 | 04/30/2024 | 04/30/2023 | 04/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 56.9M +13.54% | 50.2M -6.90% | 53.9M +9.69% | 49.1M +19.66% | |
Cost of Revenue | 28.4M -3.44% | 29.4M -0.44% | 29.5M +24.97% | 23.6M +10.19% | |
Gross Profit | 28.6M +37.59% | 20.8M -14.73% | 24.3M -4.47% | 25.5M +30.02% | |
Sales and Marketing Expense | 7.5M +6.81% | 7.1M +0.89% | 7.0M +9.77% | 6.4M +15.56% | |
Research and Development Expense | -6.8M -28.49% | -9.5M -17.33% | -11.5M +23.16% | -9.4M +30.27% | |
Depreciation and Amortization Expense | 1.6M -12.16% | 1.9M -16.87% | 2.2M +38.05% | 1.6M +37.42% | |
Total Operating Expenses | 28.4M -3.44% | 29.4M -0.44% | 29.5M +24.97% | 23.6M +10.19% | |
Operating Profit | 4.6M +161.90% | -7.4M +39.95% | -5.3M -965.90% | 607,000 +65.85% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 73,000 +52.08% | 48,000 +536.36% | -11,000 -54.17% | -24,000 -133.80% | |
Income before Taxes | 4.6M +163.30% | -7.3M +38.75% | -5.3M -1,003.43% | 583,000 +33.41% | |
Income Taxes | -75,000 +134.38% | -32,000 -147.06% | 68,000 +94.29% | 35,000 -53.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 4.7M +164.61% | -7.3M +36.38% | -5.3M -1,073.54% | 548,000 +51.38% | |
Net Income from Continuing Operations Applicable to Common | 4.6M +163.30% | -7.3M +38.75% | -5.3M -1,003.43% | 583,000 +33.41% | |
Basic EPS and Net Income | 0.34 +162.96% | -0.54 +38.46% | -0.39 -1,075.00% | 0.04 +33.33% | |
Diluted EPS and Net Income | 0.33 +161.11% | -0.54 +38.46% | -0.39 -1,075.00% | 0.04 +100.00% | |
Basic Weighted Average Shares | 13.7M +0.83% | 13.5M +0.04% | 13.5M +2.61% | 13.2M +0.44% | |
Diluted Weighted Average Shares | 14.3M +5.31% | 13.5M +0.04% | 13.5M -4.37% | 14.2M -2.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.8M +273.76% | 2.6M -74.13% | 10.1M +12.33% | 9.0M +92.17% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 9.8M +273.76% | 2.6M -74.13% | 10.1M +12.33% | 9.0M +92.17% | |
Total Current Assets | 22.4M +64.01% | 13.6M -29.90% | 19.5M -1.05% | 19.7M +55.69% | |
Accumulated Depreciation | 11.7M +12.48% | 10.4M +20.41% | 8.6M +54.74% | 5.6M +40.98% | |
Property and Plant and Equipment and Net | 4.4M -23.53% | 5.7M -20.39% | 7.2M +0.73% | 7.1M +17.14% | |
Total Long-Term Assets | 185,000 0.00% | 185,000 +1,133.33% | 15,000 0.00% | 15,000 0.00% | |
Total Assets | 32.3M +23.77% | 26.1M -23.84% | 34.3M -3.02% | 35.4M +28.22% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 23.9M +10.73% | 21.5M -0.88% | 21.7M +24.34% | 17.5M +56.08% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 85,000 -78.80% | 401,000 -27.22% | 551,000 +40.92% | 391,000 +116.02% | |
Total Liabilities | 28.6M +1.92% | 28.0M -5.53% | 29.7M +12.91% | 26.3M +30.35% | |
Retained Earnings | -79.9M -5.56% | -84.6M +9.41% | -77.3M +7.41% | -72.0M -0.76% | |
Total Stockholders Equity | 3.8M +298.21% | -1.9M -141.05% | 4.6M -49.03% | 9.1M +22.46% | |
Total Shares Outstanding | 13.8M +1.61% | 13.6M +0.11% | 13.5M +0.16% | 13.5M +0.81% | |
Cash Flow | |||||
Cash from Operating Activities | 7.4M +220.35% | -6.1M -254.51% | 4.0M -38.86% | 6.5M +486.50% | |
Capital Expenditures | 389,000 -53.47% | 836,000 -70.89% | 2.9M +20.47% | 2.4M -27.34% | |
Cash from Investing Activities | -389,000 -53.47% | -836,000 -70.89% | -2.9M +20.47% | -2.4M -24.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 170,000 +132.26% | -527,000 -4,890.91% | 11,000 -94.69% | 207,000 -82.68% | |
Financials Ratio | |||||
Gross Margin | 50.15% +21.18% | 41.38% -8.41% | 45.18% -12.91% | 51.88% +8.66% | |
Operating Margin | 8.00% +154.52% | -14.67% +50.32% | -9.76% -889.39% | 1.24% +38.60% | |
Return on Assets | 16.08% +166.78% | -24.08% +57.24% | -15.31% -979.68% | 1.74% +16.21% | |
Return on Equity | 503.05% +194.48% | -532.46% +585.26% | -77.70% -1,271.48% | 6.63% +16.77% | |
Revenue Growth | 13.54% +296.28% | -6.90% -171.13% | 9.69% -50.69% | 19.66% -29.17% | |
Current Ratio | 0.94 +48.10% | 0.63 -29.28% | 0.90 -20.42% | 1.13 -0.25% | |
Cash Ratio | 0.41 +237.61% | 0.12 -73.90% | 0.47 -9.64% | 0.52 +23.13% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow